FDA Inspection
Integris Baptist Medical Center IRBIntegris Baptist Medical Center IRB – FDA Inspection, Mar 4, 2016
Record Details
This FDA Inspection record concerns Integris Baptist Medical Center IRB, with an inspection on March 4, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 4, 2016
- Product Type
- Drugs
View Company Profile
ID · ccf2ad92-ed9b-4d04-bc15-987efc9389a9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 961043
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 56.104(c)Emergency use and IRB approval
- 21 CFR 56.108(a)(1)Initial and continuing reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Integris Baptist Medical Center IRB
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 21, 2022 | NAI | Bioresearch Monitoring |
Other documents for Integris Baptist Medical Center IRB
- FDA Inspection 1193918 - 2022-12-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.